Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
Rhea-AI Summary
Certara (NASDAQ:CERT) will release fourth quarter and full year 2025 financial results before market open on February 26, 2026. Management will host a conference call to discuss results at 8:30 AM ET. Investors must register online and are advised to register at least one day early. A live and archived webcast will be available in the Investors section of Certara's website.
Positive
- None.
Negative
- None.
News Market Reaction – CERT
In the Jan 29 session, CERT declined 1.49%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 11 | CEO appointment | Positive | -5.1% | New CEO Jon Resnick named with reaffirmed full-year 2025 outlook. |
| Nov 06 | Q3 2025 earnings | Positive | -2.6% | Q3 revenue growth, margin strength, and raised full-year 2025 guidance. |
| Nov 04 | Product launch | Positive | -1.3% | Launch of Phoenix Cloud TFL Studio to automate regulatory workflows. |
| Oct 31 | Investor conferences | Neutral | +2.4% | Announcement of participation in multiple November investor conferences. |
| Oct 30 | AI platform launch | Positive | +2.4% | Introduction of Certara IQ, an AI-driven QSP biosimulation platform. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows multiple positive operational and financial updates followed by negative price reactions, indicating a tendency for the stock to sell off on good news, with only some events aligning positively.
Over the last few months, CERT reported solid Q3 2025 growth with raised full-year 2025 guidance on Nov 6, 2025, yet the stock declined after that earnings release. Product launches like Certara IQ (Oct 30, 2025) and Phoenix Cloud’s TFL Studio (Nov 4, 2025) also saw mixed to negative reactions. Leadership changes, including appointing Jon Resnick as CEO effective Jan 1, 2026, coincided with a further price drop. Today’s earnings date announcement fits into this backdrop of active corporate developments against a pressured share price near the lower half of its 52-week range.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2025 before market open on Thursday, February 26th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Visit us at www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
